Punnonen, Juha,Beaumont, Maribel,Buyse, Marie-Ange,Boutton, Carlo,Dombrecht, Bruno,Victor, Bjorn,Kastelein, Robert A.
申请号：
AU2016355569
公开号：
AU2016355569A1
申请日:
2016.11.17
申请国别(地区):
AU
年份:
2018
代理人:
摘要：
The present invention provides molecules, such as ISVDs and Nanobodies, that bind to CTLA4 or human serum albumin. These molecules have been engineered so as to reduce the incidence of binding by pre-existing antibodies in the bodies of a subject administered such a molecule. Methods for increasing immune response, treating cancer and/or treating an infectious disease with such molecules are provided.
